SURMOUNT-3 Study
Brief description of study
Does losing weight seem out of reach? Consider the SURMOUNT-3 Study. The purpose of this 84-week randomized controlled trial is to compare the effect of a medication to a placebo in reducing body weight. The medication is a self-administered injection that is designed to help participants with weight management.
Detailed description of study
All participants will receive 12 weeks of intensive lifestyle modification (diet, exercise, and behavioral treatment). Participants who lose weight at least 5% of initial weight will be randomly assigned to one of two groups, medication or placebo, for 72 weeks. All participants will receive nutrition counseling. Visits will be held at the University of Pennsylvania.
Study drug and study procedures will be provided at no cost to you. Reimbursements for travel expenses and compensation for study inconvenience fees will be provided.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Obesity,Overweight,Weight Loss,Eating Disorder
-
Age: Between 18 Years - 100 Years
-
Gender: All
You may qualify for participation if:You have a BMI greater than 27 kg/m²You do not have Types 1 or 2 diabetesYou are available to come to Philadelphia for study visitsYou have not lost more than 10 pounds weight loss in the past 3 months
Updated on
14 Jul 2023.
Study ID: 848385